Related Experiment Video

Updated: Jul 13, 2026

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
08:49

Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome

Published on: September 23, 2015

Serotonin (5-HT) in veins: not all in vain

A Elizabeth Linder1, Wei Ni, Jessica L Diaz

  • 1Department of Pharmacology and Toxicology, Michigan State University, B445 Life Sciences Building, East Lansing, MI 48824, USA. linderau@msu.edu

The Journal of Pharmacology and Experimental Therapeutics
|August 3, 2007
PubMed

Insights

Veins, often overlooked in cardiovascular research, store higher intracellular levels of 5-hydroxytryptamine (serotonin) than arteries. This finding suggests veins may be a significant reservoir for serotonin and a potential drug target.

Area of Science:

  • Cardiovascular Physiology
  • Pharmacology
  • Biochemistry

Background:

  • Veins, accommodating 70% of blood volume, are understudied compared to arteries.
  • The role of 5-hydroxytryptamine (serotonin) in cardiovascular function remains unclear.
  • Platelets are the primary source of systemic serotonin.

Purpose of the Study:

  • To review the intersection of 5-hydroxytryptamine (serotonin) and the venous system.
  • To investigate the physiological relevance of serotonin in venous function.
  • To highlight veins as a potential therapeutic target for serotonergic drugs.

Main Methods:

  • Literature review on serotonin and venous physiology.
  • Experimental investigation of intracellular serotonin levels in veins versus arteries.
  • Assessment of serotonin uptake capabilities in venous tissue.

Main Results:

  • Veins demonstrate significantly higher intracellular concentrations of 5-hydroxytryptamine (serotonin) compared to arteries.
  • Evidence suggests that veins possess the capacity for 5-hydroxytryptamine (serotonin) uptake.
  • The venous system is proposed as a peripheral reservoir for systemic serotonin.

Conclusions:

  • The venous system plays a crucial role in regulating peripheral serotonin levels.
  • Veins represent a novel and important target for modulating the serotonergic system.
  • Further research into venous diseases and their interaction with the serotonergic system is warranted.

More Related Videos

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area09:54

Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

Published on: August 10, 2012

Related Concept Videos

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla01:27

Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla

The sympathetic pathways of the collateral ganglia and adrenal medulla serve unique but interconnected roles in the sympathetic response.
Collateral Ganglia
Sympathetic preganglionic axons reach the collateral ganglia along the route of splanchnic nerves. These nerves bypass the sympathetic trunk and communicate with sympathetic postganglionic neurons housed in the prevertebral ganglia. These ganglia supply the organs of the abdominopelvic cavity.
The greater splanchnic nerve, formed by the...
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Neurotransmitters01:31

Neurotransmitters

Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.